Effect of a tomato sauce (OsteoCol) from vine-ripened tomatoes on lipids

ISRCTN ISRCTN13244115
DOI https://doi.org/10.1186/ISRCTN13244115
Secondary identifying numbers 06/2018/CE
Submission date
14/05/2019
Registration date
16/05/2019
Last edited
12/01/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Intake of a tomato sauce with a high carotenoid (antioxidant) content in association with other lifestyle interventions may be a treatment for patients affected by common hypercholesterolemia (high blood cholesterol). Most studies focused on the benefits of lycopene, an antioxidant contained in tomato, on serum lipids but no studies have been specifically designed to assess the role of a tomato sauce from vine-ripened tomatoes (thus, naturally high in carotenoids) on patients affected by common hypercholesterolemia. The aim of this study is to investigate the effects of a tomato sauce from vine-ripened tomatoes on lipids and compare the effects with a well-known commercialized functional food with a lipid-lowering effect, a sterol-enriched yoghurt.

Who can participate?
Patients aged over 40 with polygenic hypercholesterolemia who are not taking medications or supplements

What does the study involve?
Participants are randomly allocated to consume either a functional tomato sauce or a sterol-enriched yoghurt every day for 6 weeks. Participants also receive oral and written recommendations to adhere to a Mediterranean dietary pattern, without energy restriction.

What are the possible benefits and risks of participating?
Participants receive continuous clinical support as well as cholesterol reduction with safe and natural methods. There are no risks of participating in the study because tomato sauce is obtained with natural methods and the yoghurt with sterols is already commercialised. If cholesterol increases, appropriate drugs are prescribed.

Where is the study run from?
University Magna Grecia (Italy)

When is the study starting and how long is it expected to run for?
September 2017 to May 2020

Who is funding the study?
1. University Magna Grecia Catanzaro (Italy)
2. Italian Society for the Study of Atherosclerosis (SISA) (Italy)

Who is the main contact?
1. Prof. Tiziana Montalcini
tmontalcini@unicz.it
2. Prof. Arturo Pujia
pujia@unicz.it

Contact information

Prof Tiziana Montalcini
Scientific

viale S .Venuta Università Magna Grecia
Catanzaro
88100
Italy

Phone +39 (0)3316718386
Email tmontalcini@unicz.it
Prof Arturo Pujia
Scientific

viale S. Venuta
Catanzaro
88100
Italy

Phone +39 (0)3316718206
Email pujia@unicz.it

Study information

Study designRandomized cross-over study
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleEffect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia
Study acronymOsteoCol
Study hypothesisMost studies focused on the benefits of lycopene on serum lipids but no studies have been specifically designed to assess the role of a tomato sauce from vine-ripened tomatoes on patients affected by polygenic hypercholesterolemia. This study will compare the lipid-lowering effect of this functional tomato sauce with a well-known commercialized functional food with a lipid-lowering effect, i.e. a sterol-enriched yoghurt.
Ethics approval(s)Approved 18/01/2018, local ethical committee at the “Mater Domini” Azienda University Hospital (viale T. Campanella, Catanzaro, Italy; Tel: +39 (0)961 712 111; Email: comitatoetico@hot.mail.it; michelangelo.rossano@regione.calabria.it), ref: 06/2018/CE
ConditionPolygenic hypercholesterolemia
InterventionParticipants are randomised by simple randomization to:
1. A functional tomato sauce [namely OsteCol (registered Patent), from tomatoes ripened on-the-vine], 150 ml/day (by C.G. Food, SRL, Soverato, Italy)
2. A sterol-enriched yoghurt (100 g/die of Danacol, containing sterols 1.6 g/die, by Danone, SPA, Milano, Italy).

Participants will receive oral and written recommendations to adhere to a Mediterranean dietary pattern, without energy restriction. Macronutrient distribution as a percentage of total energy range from 50% to 55% carbohydrate, 15% to 20% protein and 20% to 35% fat, with a recommended protein intake of 1 g/kg of ideal body weight. Duration: 6 weeks.
Intervention typeOther
Primary outcome measure1. Total cholesterol measured by chemiluminescent immunoassay on COBAS 8000 (Roche, Switzerland), according to the manufacturer’s instructions at baseline and 6 weeks
2. LDL-cholesterol calculated by the Friedewald formula at baseline and 6 weeks
Secondary outcome measuresLDL-cholesterol according with basal LDL-tertiles measured at baseline and 6 weeks
Overall study start date01/09/2017
Overall study end date30/05/2020

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants108
Total final enrolment108
Participant inclusion criteria1. Individuals with polygenic hypercholesterolemia
2. Both genders
3. Aged over 40 years
4. Not taking medications or supplements
Participant exclusion criteria1. Familial hypercholesterolemia
2. Triglycerides concentration over 200 mg/dl
3. Secondary causes of hyperlipidemia
4. Debilitating diseases, as ascertained
Recruitment start date01/02/2018
Recruitment end date09/05/2018

Locations

Countries of recruitment

  • Italy

Study participating centre

University Magna Grecia
viale S. Venuta
Catanzaro
88100
Italy

Sponsor information

University Magna Grecia Catanzaro
University/education

Clinical Nutrition Unit
viale S. Venuta
95/1
Catanzaro
88100
Italy

Phone +39 (0)3316718206
Email pujia@unicz.it
Website https://web.unicz.it/it/
ROR logo "ROR" https://ror.org/0530bdk91

Funders

Funder type

University/education

University Magna Grecia Catanzaro

No information available

Italian Society for the Study of Atherosclerosis (SISA)

No information available

Results and Publications

Intention to publish date30/06/2020
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planThe researchers will submit results in 2019/20 to scientific journals with an impact factor as well as popular magazines.
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Tiziana Montalcini (tmontalcini@unicz.it).
Type of data: Excel file.
When the data will become available: 30/05/2020.
For how long: currently not known.
Access criteria data will be shared including with whom, for what types of analyses: descriptive analysis of the population.
The researchers need to guarantee data anonymisation, all requests will be approved by the Principal Investigator.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 06/01/2021 12/01/2021 Yes No

Editorial Notes

12/01/2021: Publication reference added.
15/08/2019: The following changes were made to the trial record:
1. The recruitment end date was changed from 30/07/2019 to 09/05/2018.
2. The total final enrolment number was added.
15/05/2019: Trial's existence confirmed by local ethics committee.